Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Primary Endoscopic Frontal Sinus Surgery Grade 6 (Draf III) in Patients With Moderate to Severe Eosinophilic Chronic Rhinosinusitis With Polyps

NCT05979662 is registered in ClinicalTrials.gov with Ibrahim Talal Elshamy as lead sponsor.

NCT NCT05979662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05979662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Primary Endoscopic Frontal Sinus Surgery Grade 6 (Draf III) in Patients With Moderate to Severe Eosinophilic Chronic Rhinosinusitis With Polyps
Lead sponsor
Ibrahim Talal Elshamy
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2021
Completion date
September 30, 2023
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis with nasal polyps, draf i or iia, draf iii, endoscopic frontal sinus surgery